Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ITIH4 antisense RNA 1 (ITIH4-AS1) is a long non-coding RNA (lncRNA) transcribed from the DNA strand antisense to the ITIH4 gene. As an antisense RNA, its main molecular function is regulation of ITIH4 expression, likely via modulating the stability, translation, or transcription of ITIH4 mRNA[6][7]. In cancer, specifically colorectal cancer, ITIH4-AS1 has been shown to accelerate cell proliferation and metastasis by activating the JAK/STAT3 signaling pathway, possibly by facilitating the nuclear translocation of phosphorylated STAT3 through interactions with the RNA-binding protein FUS[3]. ITIH4-AS1 is not a receptor, enzyme, or classical drug target, but rather an RNA molecule involved in gene regulation and cancer progression. It is not currently known to interact directly with any drugs, nor are there established mechanisms of therapeutic action, biomarkers, or safety concerns specific to ITIH4-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ITIH4 antisense RNA 1 (ITIH4-AS1).